SEONGNAM, South Korea, Oct. 15, 2025 /PRNewswire/ -- SK bioscience announced that it has submitted a Phase 1/2 clinical trial application in Australia for GBP511, a universal coronavirus vaccine ...
A researcher at SK bioscience conducts an analytical experiment for vaccine development. Sarbecoviruses, a subgenus of coronaviruses, include SARS-CoV-2 (COVID-19), the original SARS virus, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results